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Abstract
Background: The relationship between apathy, depression and cognitive impairment in Parkinson’s disease (PD) is still
controversial. The objective of this study is to investigate whether apathy and depression are associated with inefficient
cognitive strategies in PD.
Methods: In this prospective clinical cohort study conducted in a university-based clinical and research movement disorders
center we studied 48 PD patients. Based on clinical evaluation, they were classified in two groups: PD with apathy (PD-A
group, n = 23) and PD without apathy (PD-NA group, n = 25). Patients received clinical and neuropsychological evaluations.
The clinical evaluation included: Apathy Evaluation Scale-patient version, Hamilton Depression Rating Scale-17 items, the
Unified Parkinson’s Disease Rating Scale and the Hoehn and Yahr staging system; the neuropsychological evaluation
explored speed information processing, attention, working memory, executive function, learning abilities and memory,
which included several measures of recall (immediate free, short delay free, long delay free and cued, and total recall).
Findings: PD-A and PD-NA groups did not differ in age, disease duration, treatment, and motor condition, but differed in
recall (p,0.001) and executive tasks (p,0.001). Immediate free recall had the highest predictive value for apathy (F = 10.94;
p = 0.002). Depression and apathy had a weak correlation (Pearson index = 0.3; p,0.07), with three items of the depression
scale correlating with apathy (Pearson index between .3 and.4; p,0.04). The depressed and non-depressed PD patients
within the non-apathetic group did not differ.
Conclusion: Apathy, but not depression, is associated with deficit in implementing efficient cognitive strategies. As the
implementation of efficient strategies relies on the fronto-striatal circuit, we conclude that apathy, unlike depression, is an
early expression of executive impairment in PD.
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Introduction
Apathy is a reduction of spontaneous and goal-directed
behaviors, making affected individuals less responsive and less
engaged in daily activities [1]. As a syndrome, apathy affects three
domains of the human being. In the behavior domain, apathy
expresses itself as lack of effort, lack of productivity, and
dependency on others for structured activities. The cognitive
domain is affected as loss of interest in novel experiences. Apathy,
finally, expresses itself in the emotional domain as a lack of
response to positive or negative events, and as lack of concern
about one’s problems.
In Parkinson’s disease (PD), apathy has a high prevalence,
ranging from 17 to 70% [2]. Although apathy and depression have
been clearly dissociated as independent syndromes in PD [3],
symptoms of apathy and depression may also overlap [4].
Recognition of apathy in PD patients is difficult and requires a
structured interview. Several instruments have been developed
and validated to this scope [5].
Detecting apathy in PD patients has important prognostic
implications, as apathy is a predictive factor for the development of
dementia [6] and is associated with cognitive dysfunction [6–11].
The majority of the studies have highlighted the presence of
executive impairments in apathetic PD patients. Pluck and Brown
[7] reported that PD patients with apathy have also a worse
performance in memory tasks [12]. At first glance, the diversity of
cognitive impairments makes the association between these deficits
and apathy somehow difficult to explain and interpret. However,
executive and memory domains might share a common cognitive
core accounting for the variability seen in apathetic PD patients.
Here, our hypothesis is that in PD, the impaired implementa-
tion of novel cognitive strategies has a pivotal role in the inefficient
storing and recalling of new information as well as in abstract
reasoning and problem solving. We propose that this altered
mechanism is the underpinning of both apathy and cognitive
dysfunction in PD. The identification of a common core may help
to clarify the nature of apathy in the context of PD. Specifically,
the primary aim of the current study is to investigate whether
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impaired implementation of novel cognitive strategies may
account for the neuropsychological deficits observed in patients
with PD and apathy. As secondary aim, we intended to
disentangle in these patients the independent contribution of
apathy and depression to the cognitive functioning. Thus, we
compared the cognitive performance of apathetic and non-
apathetic patients with PD, weighted on the clinical factors that
could potentially bias the neuropsychological outcomes. In
addition, in order to understand the impact of depression, the
neuropsychological scores of depressed and non-depressed patients
within the non-apathetic group were investigated separately.
Methods
Patients
Forty-eight patients were recruited prospectively and consecu-
tively from a cohort of patients referred to the study by their
clinicians at our Movement Disorders Center. To be included in
this study they had to meet the UK brain bank Criteria for PD
[13], were not being treated with antidepressants, had not been
diagnosed with dementia or had a Mini Mental State Evaluation
(MMSE) [14] total score below 25, and had to be fluent in English.
In order to standardize the evaluations to the best possible
condition, all patients were evaluated in on state and under their
regular anti-parkinsonian treatment. Doses of dopaminergic
medication were converted to equivalent L-dopa doses (LED) [15].
Procedures and materials
All the evaluations conducted in this study were previously
approved by the NYU Institution Review Board, and all subjects
signed a written consent form before undergoing the assessment.
The severity of disease was rated using the Unified Parkinson’s
Disease Rating Scale (UPDRS) [16] and the Hoehn and Yahr
ranging system [17]. Depressive symptoms were rated using the
Hamilton Disease Rating Scale (HAMD-17) [18]. Apathy was
investigated using the Apathy Evaluation Scale (AES), patient-
rated version [19], and as per current recommendation [5] a score
$38 was considered positive for apathy.
A comprehensive neuropsychological evaluation was conducted
to investigate the following cognitive domains: attention, speed
information processing, learning, memory (recall and recognition),
working memory, and executive functions. Each domain was
investigated through measures extracted from multiple neuropsy-
chological tools.
The spatial [20] and the digit span backwards [21] were used to
assess working memory abilities. The digit symbol [21] and the
visual scanning test from the Delis-Kaplan Executive Function
system (D-KEFS) [22] were used to rate attention. The speed
information processing was investigated using the number
sequencing and the letter sequencing tasks of D-KEFS [22]; in
order to exclude the effect of bradykinesia on the test performance,
we used the formula: [(raw score- motor speed score)/motor
speed]. In the memory domain, short term memory was
investigated using the digit [21] and spatial span forward tests
[20]; recall was investigated using the immediate free recall, the
short delay free recall, the long delay free and long delayed cued
scores of the California Verbal Learning Test –II (CVLT-II) [23];
recognition was measured using the delayed recognition score of
the CVLT-II [23]; learning was assessed using the total learning
slope of the CVLT-II [23]. Executive functions were evaluated
using the Wisconsin Card Sorting Test (WCST) - 64 cards version
[24]; specifically, 4 measures were extracted: perseverative
responses, in order to evaluate the ability to shift; total correct
responses, non-perseverative responses and categories completed
to evaluate the abstract reasoning. Along with the WCST, the
number-letter switching task from the D-KEFS was used to assess
the executive control and shifting ability.
A trained investigator conducted all the evaluations in a
comfortable room, suitable for motor and neuropsychological
testing. Both the clinical and the neuropsychological evaluation
required about 1 hour each to be completed and they were
conducted in the same day.
For the statistical analysis only raw scores were considered.
Statistical analysis
The first step of the analysis aimed at testing the cognitive
differences between apathetic (PD-A) and non-apathetic (PD-NA)
patients. The AES cut-off score of 38 divided the patients into two
subgroups: PD-A group included individuals scoring 38 or above,
and PD-NA group consisted of subjects scoring below 38.
Differences in gender, Hoehn and Yahr stage and disease side of
onset were explored using the x2 test for categorical variables.
Differences in age, years of education, UPDRS motor score,
HAMD-17 score and LED were investigated using the indepen-
dent sample t-test. The cognitive profile of the two groups was
then compared. For each neuropsychological raw score, we
performed univariate analysis of variance, with age, years of
education, disease duration and treatment (LED) as covariates
(ANCOVA), as these variables might affect cognition. In our
model the fixed factor was represented by the group membership




age 67.4 (9.2) 67.1 (12.5) 0.9
gender (F/M) 11/8 14/15 0.6
education 14.1 (3.6) 15.3 (3.1) 0.2
disease duration 5.9 (3.6) 8.6 (7.9) 0.1
MMSE 28 (1.8) 29.4 (1.1)
AES 47.3 (5.5) 29.1 (5.3) 0.000*
HAMD-17 17.6 (6.8) 12 (6.8) 0.007*
UPDRS III 24 (10) 22.6 (10) 0.6
hypomimia 1.5 (0.7) 1.4 (0.6) 0.6
tremor 2.9 (3.5) 2.2 (2.8) 0.4
rigidity 4.8 (3.1) 3.9 (2.7) 0.2
bradykinesia 10.8(4.2) 10.3 (5.3) 0.7
axial impairment 3.8 (1.9) 2.9 (2.2) 0.2
H&Y stage 0.8
stage 1 1 3
stage 2 13 14
stage 3 7 7
stage 4 1 1
side of onset (R/L) 16/6 12/12 0.8
LED 638 (326.3) 896.8 (594.4) 0.07
All values represent mean (SD). P values have been calculated using
independent sample t-test for parametric variables and x2 for categorical
variables. P,0.05, FDR corrected.
MMSE = Mini Mental State; AES = Apathy Evaluation Scale-patient rated; UPDRS
III = Unified Parkinson’s Disease Rating Scale, part III (motor); H&Y stage =
Hoehn and Yahr stage; LED = L-Dopa Equivalent Dose.
doi:10.1371/journal.pone.0017846.t001
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apathy and the specific motor signs of PD, five domains were
extracted from the UPDRS III: hypomimia (item 19), tremor
(items 20 and 21); rigidity (item 22), bradykinesia (items 23, 24, 25,
26, 31), and axial impairment (item 27, 28, 29, 30) [25]. The
group differences were studied with ANCOVA as described
above. All the assumptions for using the ANCOVA methods were
fulfilled (reliability of covariates, correlations among covariates,
and linear relationship between dependent variable and covariate,
and homogeneity of variance as revealed by the Levene’s test and
the variance ratio, also know as Hartley’s Fmax). Differences were
considered significant when the p values were below 0.05. False
Discovery Rate procedure was used to correct for multiple
comparisons. After testing the differences in cognition between the
groups, to ascertain which variables best predicted apathy scores,
all the variables showing significant differences between the two
groups in the ANCOVA analyses were entered in a stepwise
regression procedure.
A second step of the analysis sought to evaluate the effect of
depression on cognitive performance: first, we assessed the
relationship between apathy and depression by correlating the
AES and HAMD-17 total scores (Pearson index); then, we
investigated the overlap of apathy into the HAMD-17 questionnaire
by computing Pearson’s coefficients between the single HAMD-17
item scores and AES total score. Moreover, applying to the accepted
HAMD-17 cut off score of 9 for PD [26], we identified within the
NA-PD group, a subgroup without depression (NA-PD non-
depressed group) and a subgroup with depression (NA-PD
depressed group). The neuropsychological scores of the two
subgroups were compared using ANCOVA as described above.
To further ascertain the contribution of depression on the
relation between apathy and cognitive functioning we performed
multiple regressions procedures (enter method) on those test scores
that significantly differed between the PD-A and PD-NA groups.
The variables entered into the analysis were: AES score, HAMD-
17, age, education, disease duration and LED. The analysis was
performed on the entire sample of patients.
All the analyses were conducted using the statistical software
SPSS v.17.
Results
Demographic and clinical characteristics
Based on the AES cut off score of 38, 23 patients were classified
in the PD-A group and 25 were classified in the PD-NA group. No
differences were found between the two groups with respect to age,
gender, disease severity, disease duration, side of onset, although
the HAMD-17 scores were significantly higher in the PD-A group
(p = 0.007); apathy was not associated with any specific motor sign
and the groups were receiving similar doses of dopaminergic
treatments (Table 1).
Neuropsychological performance
PD-A patients performed worse than PD-NA patients in 10 out
of the 20 neuropsychological measures.
In the working memory, PD-A groups had lower scores at the
backward version of the digit span (p = 0.01). All the other
differences were found in the CVLT-II and the WCST-64.
Specifically, the PD-A patients had lower scores in the recall after
Table 2. Neuropsychological performance.
Domain Test Measure PD-A PD-NA Sig. g2
Short term memory SS forward 6.9 (1.6) 7.8 (2.2) 0.15 0.05
DS forward 8.9 (2.3) 10.1 (2.9) 0.36 0.02
Recall CVLT-II trials 1–4 total 22.8 (5.8) 28 (3.7) 0.002* 0.22
CVLT-II short delay free 5.9 (2.3) 7.4 (1.2) 0.003* 0.2
CVLT-II long delay free 5 (2.2) 7.2 (1.5) 0.000* 0.31
CVLT-II long delay cued 5.1 (2.1) 7.4 (1.9) 0.001* 0.26
Recognition CVLT-II delayed recognition 8 (0.8) 8.6 (0.6) 0.008* 0.16
Learning CVLT-II trial 4-trial1 3 (1.2) 2.8 (1.1) 0.6 0
Working Memory SS backward 5.9 (2.1) 6.7 (2.5) 0.1 0.07
DS backward 5.6 (1.9) 7.4 (2.3) 0.01* 0.13
Attention D-KEFS visual scanning 35.9 (17.4) 33.2 (12.4) 0.89 0
DSy 44.9 (16.5) 51.4 (15.2) 0.29 0.03
Speed information
processing
D-KEFS number sequence (weight) 0.4 (0.9) 0.3 (0.5) 0.6 0.07
letter sequence (weight) 0.6 (1) 0.2 (0.4) 0.2 0.05
motor speed 52.4 (32) 45 (22.5) 0.3 0.03
Executive functions WCST-64 total correct 34.9 (10.8) 45.6 (11.2) 0.002* 0.22
perseverative responses 14.9 (7.9) 12.1 (11.5) 0.36 0.02
non-perseverative errors 15.6 (8.5) 8.3 (5.2) 0.001* 0.23
categories completed 1.6 (1.3) 3.2 (1.7) 0.001* 0.23
D-KEFS number-letter (weight) 2.5 (1.5) 1.7 (1) 0.07 0.07
All values represent mean (SD). Between-groups comparisons have been investigating using univariate analysis of variance for each variable, with age, disease duration
and Led as covariates and group membership (apathy vs. No apathy) as fixed factor (ANCOVA). The g2 statistic was used to estimate the effect size. P ,0.05, FDR
corrected. D-KEFS = Delis-Kaplan Executive Function system; CVLT-II = California Verbal Learning Test –II; WCST-64 = Wisconsin Card Sorting Test-64 cards version;
SS = Spatial Span; DS = Digit Span; DSy = Digit symbol.
doi:10.1371/journal.pone.0017846.t002
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the four trials at the CVLT-II (p = 0.002), in the short delay free
recall (p = 0.003), in the long delay free recall (p,0.0001), and in
the long delay cued recall (p = 0.001). Delayed recognition was
impaired as well in the PD-A patients (p = 0.008), while no
difference was found in learning slope (p = 0.6). The WCST-64
revealed that the PD-A group had poor ability in abstract
reasoning but not in adaptation to external feedback, with a lower
number of correct responses (p = 0.002), higher rates of errors
(p = 0.001), and lower number of categories completed (p = 0.001).
Notably, the number of perseverative responses did not differ
among the groups (p = 0.4). The performance at the D-KEFS was
similar in the groups, suggesting that visual information processing
and set-shifting are not related to apathy.
The neuropsychological performances of the groups are
summarized in Table 2.
Regression analysis
The CVLT-II total recall score proved to be the best predictor
of apathy (R = 0.44; F = 10.94; p = 0.002) in the stepwise
regression analysis of the neuropsychological measures tested.
Secondary analysis on depression
Since the PD-A and PD-NA groups showed significant
differences in HAMD-17 total score, we conducted a series of
analysis to determine the impact of depression on cognitive
performance. First, we found a weak association between apathy
(AES total scores) and depression (HAMD-17) in the entire PD
population (r = 0.30, p = 0.03). However, since such correlation
and the differences between the PD-A and PD-NA groups in the
depression scale could have resulted from specific HAMD-17
items reflecting apathy trait, we correlated each HAMD-17 item
with the AES total score. Indeed, we found that three out of the 17
items showed positive correlation: item 7, investigating interest in
daily work and other activities (Pearson index = 0.33; p = 0.022);
item 8, investigating retardation in response (Pearson index = 0.38;
p = 0.007); item 13, investigating the somatic general symptoms
(Pearson index = 0.38; p = 0.003).
In a second step of the analysis, we studied the impact of
depression on cognition within the PD-NA sample. Based upon the
suggested score for depression in PD [16], fifteen patients with a
HAMD-17 score above 9 were considered depressed (Table 3). The
scores of the neuropsychological tests of PD-NA patients with and
without depression did not differ statistically (Figure 1, Table S1).




age 62.3 (11.4) 70.33 (12.5) 0.1
gender (F/M) 5/5 6/9 0.9
education 16.3 (0.67) 14.67 (3.8) 0.13
disease duration (years) 7.2 (5.6) 9.4 (9.3) 0.5
MMSE 29.3 (1.3) 29.5 (0.9)
AES 29.9 (4.9) 28.8 (5.8) 0.7
HAMD-17 5.1 (2.7) 16.7 (4.4) 0.000*
UPDRS III 18.5 (9.3) 25.3 (12.55) 0.09
hypomimia 1.6 (0.5) 1.4 (0.5) 1
tremor 1.9 (2.2) 2.4 (3.3) 0.4
rigidity 3 (1.5) 4.7 (3.2) 0.9
bradykinesia 8.2(5.1) 12.1 (4.9) 0.7
axial impairment 2.5 (2) 3.3 (2.4) 0.7
H&Y stage I-III II-III 0.8
side of onset (R/L) 5/5 7/8
LED 785 (612.8) 971.4 (591.1) 0.45
All values represent mean (SD).
P values have been calculated using independent sample t-test for parametric
variables and x2 for categorical variables.
MMSE = Mini Mental State; AES = Apathy Evaluation Scale-patient rated; UPDRS
III = Unified Parkinson’s Disease Rating Scale, part III (motor); H&Y stage =
Hoehn and Yahr stage; LED = L-Dopa Equivalent Dose.
doi:10.1371/journal.pone.0017846.t003
Figure 1. Recall and executive profiles of non-apathetic PD patients with and without depression. The scores are expressed as mean
score (the bar shows the standard error). None of the comparisons reaches the statistical significance. CVLT-TS = California Verbal Learning Test II-
Total recall score; CVLT-SFR: California Verbal Learning Test II-Short free recall; CVLT-LFR = California Verbal Learning Test II-Long free recall; CVLT-
LCR = California Verbal Learning Test II-Long cued recall; CVLT-Rec = California Verbal Learning Test II-Recognition; WCST-TC = Wisconsin Card
Sorting Test- Total correct; WCST-PR = Wisconsin Card Sorting Test-Perseverative responses; WCST-NoPR = Wisconsin Card Sorting Test- Non-
perseverative responses; WCST-Cat = Wisconsin Card Sorting Test- Categories completed.
doi:10.1371/journal.pone.0017846.g001
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Furthermore, apathy resulted the best predictor of cognitive
performance in the regression analysis conducted on the entire
group to ascertain the individual contribution of apathy and
depression. Interestingly, the contribution of depression was not
statistically significant (Table 4).
Discussion
The results of our study support previous evidence of the
existence of a distinct subgroup of non-demented patients with PD
with cognitive impairments associated with clinically relevant
levels of apathy. Importantly, the novel finding is that in PD,
apathy, but not depression, is associated with specific deficits of
recall and executive functions. Indeed cognitive functioning was
best predicted by apathy, while depression had no or negligible
effect. These data suggest that abnormal performance of apathetic
patients with PD likely results from implementing new and
efficient cognitive strategies. Such impairment may be at the basis
of the poor performance both in finding new categories in the
WCST (abstract reasoning) and in the recall and recognition of
words that can be acquired through categorization strategies
(CVLT-II) in PD patients with apathy.
Abstract reasoning and strategy development are classically
associated with frontal lobe functioning [27] and are sensitive to
frontal lesions as well as to functional deficits of the fronto-striatal
circuit. Apathy is commonly defined as a primary emotional
disorder. However, the model of ‘‘cognitive inertia’’ recently
proposed [28] considers apathy as a complex behavioral deficit of
self-initiation. This usually occurs as a consequence either of
dysfunction of the prefrontal cortex, or of diseases of the basal
ganglia which disrupt the associative pathways to the prefrontal
cortex. WCST is certainly a useful tool to detect frontal lobe
dysfunction. In particular, the WCST is sensitive to deficits of a
number of executive abilities as shifting of attention between sets,
abstract reasoning, and problem solving. In our study, we
observed that apathy in PD was associated with poor planning
and rule-finding, but not with set-shifting, pointing to a specific
impairment of the ability to generate new cognitive strategies.
In addition, apathy was associated with significant recall and
recognition deficits in the CVLT-II. Rather than a primary
memory disorder, this impairment is likely due to poor strategy
implementation at the encoding and the recall stages. Specifically,
a deficit of the encoding of new items may account for the
abnormal cued recall and recognition; whereas disruption of recall
may produce poor performance during the short-delay and long-
delay free retrievals.
In fact, in the CVLT-II, the words to be retained can be more
efficiently encoded and recalled by using semantic strategies, as
also confirmed by recent findings in patients with focal frontal
lesions [29]. This hypothesis, which is in agreement with other
studies in patients with traumatic brain injury [30], is supported by
our results showing that immediate CVLT-II free recall is the best
predictor of apathy. In agreement with a previous study [31], it is
unlikely that these differences can be explained by disease severity
and dopamine depletion, as the two groups did not significantly
differ regarding stage of disease, motor disability, and LED.
The main limitation of this study is that it is difficult to dismiss
completely the role of depression in our results, since concomitant
depression was not considered as an exclusion criterion. However,
the lack of correlation between depression and cognitive functions
makes depression alone an unlikely explanation for the difference
between apathetic and non-apathetic PD patients. This conclusion
is also supported by the results of the regression analysis
controlling for depression that demonstrated that apathy was the
best predictor of cognitive performance. It might be argued that
the apathetic patients had greater depressive scores. However, the
weak correlation between apathy and depression was mostly due
to the fact that the HAMD-17 contains items that specifically
Table 4. Differential contribution of apathy and depression on cognitive functioning.
Domain Test Model summary predictors Beta SE Beta Stand Beta p value
Recall CVLT-II trials 1–4 total R2 = 0.48 apathy 2 0.18 0.68 2 3.44 .014
F(6,39) = 6.1* depression 0.03 0.10 .035 .798
CVLT-II short delay free R2 = 0.51 apathy 2 0.05 0.02 2 .24 .043
F(6,39) = 6.7* depression 2 0.05 0.04 2 .20 .137
CVLT-II long delay free R2 = 0.50 apathy 2 0.07 0.03 2 .35 .01
F(6,39) = 6.5* depression 2 0.01 0.04 2 .04 .741
CVLT-II long delay cued R2 = 0.38 apathy 2 0.07 0.03 2 .31 .037
F(6,39) = 4.1* depression 2 0.05 0.05 2 .17 .256
Recognition CVLT-II delayed recognition R2 = 0.31 apathy 2 0.02 0.01 2 .33 .04
F(6,39) = 2.9‘ depression 0.02 0.02 .22 .172
Working Memory DS backward R2 = 0.28 apathy 2 0.07 0.03 2 .31 .057
F(6,39) = 2.5‘ depression 0.01 0.05 .03 .859
Executive functions WCST-64 total correct R2 = 0.49 apathy 2 0.33 0.15 2 .28 .043
F(6,39) = 6.1* depression 2 0.4 0.23 2 .24 .094
WCST-64 categories completed R2 = 0.42 apathy 2 0.05 0.02 2 .29 .050
F(6,39) = 4.5* depression 2 0.05 0.04 2 .21 .162
‘, .05,
*, .005, in bold the significant value of the predictors.
Regression analysis on the test scores that differentiated PD-NA and PD-A. The variables entered into the analysis were: AES score, HAMD-17, age, education, disease
duration and LED. The analysis was performed on the entire sample of patients. Model summary reports the R squared and the results of the ANOVA test for the
different dependent variables. We report the beta values only for the two predictors of interest (AES score and HAMD-17 score).
doi:10.1371/journal.pone.0017846.t004
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investigate and rate apathetic features. Altogether, our findings are
consistent with previous observations that apathy and depression
can occur in PD as independent clinical phenomena [3,31,32].
The dissociation between apathy and depression has important
prognostic and therapeutic implications. Unlike depression,
indeed, there is no specific treatment for apathy, although apathy
leads the patients to physical inactivity increasing the risk of
further functional decline and disability [33]. In addition,
identifying apathy with depression may be one of the reasons for
the poor response to anti-depressive treatment commonly seen in
PD. Indeed, the use of the HAMD-17, which is one of the
recommended [26] questionnaire to screen depression and
monitor treatment responses in PD, includes items that are
apathy-related and that can bring to an incorrect diagnosis of
depression.
In summary, we conclude that apathy should be considered an
early manifestation of dysexecutive syndrome in PD that reflects a
disruption of cognitive processing. Given that apathy is a predictive
factor for dementia [6], our findings may serve to encourage the
clinicians to conduct extensive neuropsychological investigations in
patients showing apathetic symptoms, in order to detect subtle
cognitive impairments. Future longitudinal studies will have to
ascertain whether apathetic PD patients are destined to develop
overt dementia, more than patients not experiencing apathy.
Supporting Information
Table S1 Neuropsychological scores of PD-NA with depression
and PD-NA without depression groups. For each neuropsycho-
logical variable the table reports the mean, standard deviation,
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